As a specialist knee surgeon in Sydney, Dr Jonathan Negus is comfortable having open conversations about emerging treatments and where they currently fit in evidence-based knee care
Tirzepatide is the first combination of entero-pancreatic hormones [dual GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) RA] that has been approved for T2D management based on the findings from the phase 3 SURPASS programme
Lifestyle modifications including structured nutrition planning, progressive resistance training, and adequate sleep remain the first-line approach for postpartum weight management
QR code on the insert for documentation, vials secure, no damage
As part of this service, the company is offering GLP-1 drugs to qualified patients in its weight management program
Our team has taken the time and evaluated the following sites